Abstract: Bioactive implant for myocardial regeneration and ventricular chamber support including an elastomeric microporous membrane. The elastomeric microporous membrane being at least one non-degradable polymer and at least one partially degradable polymer. The non-degradable polymer is selected from polyethylacrylate and polyethylacrylate copolymerized with a hydroxyethylacrylate comonomer. The partially degradable polymer is selected from caprolactone 2-(methacryloyloxy)ethyl ester and caprolactone 2-(methacryloyloxy)ethyl ester copolymerized with ethylacrylate. The elastomeric microporous membrane further includes a nanofiber hydrogel, and cells. The bioactive implant, having one or two helical loops, contributes to the restoration of the heart conical shape.

Abstract: Bioactive implant for myocardial regeneration and ventricular chamber support including an elastomeric microporous membrane. The elastomeric microporous membrane being at least one non-degradable polymer and at least one partially degradable polymer. The non-degradable polymer is selected from polyethylacrylate and polyethylacrylate copolymerized with a hydroxyethylacrylate comonomer. The partially degradable polymer is selected from caprolactone 2-(methacryloyloxy)ethyl ester and caprolactone 2-(methacryloyloxy)ethyl ester copolymerized with ethylacrylate. The elastomeric microporous membrane further includes a nanofiber hydrogel, and cells. The bioactive implant, having one or two helical loops, contributes to the restauration of the heart conical shape.

Abstract: Bioactive implant for myocardial regeneration and ventricular chamber support including an elastomeric microporous membrane. The elastomeric microporous membrane being at least one non-degradable polymer and at least one partially degradable polymer. The non-degradable polymer is selected from polyethylacrylate and polyethylacrylate copolymerized with a hydroxyethylacrylate comonomer. The partially degradable polymer is selected from caprolactone 2-(methacryloyloxy)ethyl ester and caprolactone 2-(methacryloyloxy)ethyl ester copolymerized with ethylacrylate. The elastomeric microporous membrane further includes a nanofiber hydrogel, and cells. The bioactive implant, having one or two helical loops, contributes to the restauration of the heart conical shape.

Abstract: Bioactive implant for myocardial regeneration and ventricular chamber support including an elastomeric microporous membrane. The elastomeric microporous membrane being at least one non-degradable polymer and at least one partially degradable polymer. The non-degradable polymer is selected from polyethylacrylate and polyethylacrylate copolymerized with a hydroxyethylacrylate comonomer. The partially degradable polymer is selected from caprolactone 2-(methacryloyloxy)ethyl ester and caprolactone 2-(methacryloyloxy)ethyl ester copolymerized with ethylacrylate. The elastomeric microporous membrane further includes a nanofiber hydrogel, and cells. The bioactive implant, having one or two helical loops, contributes to the restauration of the heart conical shape.

Abstract: This implant (1) for osseous fusion is intended to be inserted between two adjacent vertebral bodies (4) of a spinal column. It comprises a main body (2) having at least two longitudinal elements of C-shaped contour (2a, 2b) placed back to back and defining:—a solid axis (9), formed by the junction zone of said elements (2a, 2b) and suitable for being positioned parallel to the spinal column and for transmitting the stresses between the two adjacent vertebral bodies, and—at least two longitudinal apertures (6), suitable for holding grafts, oriented outward with respect to said solid axis (9).

Abstract: The invention relates to an aqueous composition used in the laser repair treatment of fibrous connective tissue, including: gold nanoparticles in a concentration of between 1.5×109 particles per ml and 1×1010 particles per ml; and albumin and/or collagen in a concentration of between 30 wt % and 45 wt %. The invention also relates to an assembly including such a composition.

Abstract: This implant (1) for osseous fusion is intended to be inserted between two adjacent vertebral bodies (4) of a spinal column. It comprises a main body (2) having at least two longitudinal elements of C-shaped contour (2a, 2b) placed back to back and defining:—a solid axis (9), formed by the junction zone of said elements (2a, 2b) and suitable for being positioned parallel to the spinal column and for transmitting the stresses between the two adjacent vertebral bodies, and—at least two longitudinal apertures (6), suitable for holding grafts, oriented outward with respect to said solid axis (9).

Abstract: A printing sleeve with multiple layers including a printing layer, a compressible layer, and a circumferential stiffening layer. The stiffening layer is located between the compressible layer and the printing layer.